Market Cap 346.48M
Revenue (ttm) 0.00
Net Income (ttm) -236.93M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.75
Volume 821,900
Avg Vol 1,271,916
Day's Range N/A - N/A
Shares Out 185.28M
Stochastic %K 20%
Beta 3.02
Analysts Sell
Price Target $9.14

Company Profile

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases in the United States. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in Phase 1b clinical trials in patients with agitation associ...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 760 0900
Address:
260 Arsenal Place, Suite 1, Watertown, United States
GangsterX
GangsterX May. 12 at 6:15 PM
$CHRS $NMRA small bet couple weeks ago and still holding
1 · Reply
Kaltycoon
Kaltycoon May. 12 at 6:15 PM
$LCTX $NMRA tanked 25% on slight beat and no updates, just saying as I’m invested in both
0 · Reply
Kaltycoon
Kaltycoon May. 11 at 1:16 PM
0 · Reply
Kaltycoon
Kaltycoon May. 9 at 7:30 AM
$NMRA wonder when this transaction happened timeline
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW May. 8 at 7:36 PM
$NMRA options flow has spoken, slap that ask if you want in, this is the way….
0 · Reply
Kaltycoon
Kaltycoon May. 8 at 7:16 PM
$NMRA someone made a swing short here, also bunch of people got stopped out:
0 · Reply
Only_Bulls
Only_Bulls May. 8 at 6:48 PM
$NMRA increased my position by 20% today! Let’s Goooo! Thanks for the cheapies!
0 · Reply
Kaltycoon
Kaltycoon May. 8 at 3:54 PM
$NMRA latest 10Qs are transparent, just need better and cleaner updates on trials with peer reviews. Where there is risk, there is reward.
0 · Reply
Kaltycoon
Kaltycoon May. 8 at 2:45 PM
$NMRA $MRNA the only way is up, the year of biotech
2 · Reply
InvestorCG
InvestorCG May. 8 at 2:27 PM
$NMRA These are the times that try mans souls.
0 · Reply
Latest News on NMRA
Neumora Therapeutics reports Q1 EPS (30c), consensus (31c)

2026-05-07T15:39:57.000Z - 5 days ago

Neumora Therapeutics reports Q1 EPS (30c), consensus (31c)


Neumora Therapeutics management to meet with Piper Sandler

2026-04-02T14:37:16.000Z - 5 weeks ago

Neumora Therapeutics management to meet with Piper Sandler


Neumora Therapeutics Earnings Call Transcript: Q4 2025

Mar 30, 2026, 8:00 AM EDT - 6 weeks ago

Neumora Therapeutics Earnings Call Transcript: Q4 2025


Neumora Therapeutics reports Q4 EPS (35c), consensus (33c)

2026-03-30T11:00:07.000Z - 6 weeks ago

Neumora Therapeutics reports Q4 EPS (35c), consensus (33c)


Neumora Therapeutics management to meet virtually with Needham

2026-03-02T18:05:39.000Z - 2 months ago

Neumora Therapeutics management to meet virtually with Needham


Neumora Therapeutics initiated with an Outperform at Leerink

2026-01-12T10:25:32.000Z - 4 months ago

Neumora Therapeutics initiated with an Outperform at Leerink


Neumora Therapeutics Transcript: Study Result

Jan 5, 2026, 8:00 AM EST - 4 months ago

Neumora Therapeutics Transcript: Study Result


Neumora Therapeutics highlights 2026 pipeline strategy

2026-01-05T11:41:35.000Z - 4 months ago

Neumora Therapeutics highlights 2026 pipeline strategy


LB Pharmaceuticals appoints Kaya Pai Panandiker as CCO

2025-11-12T13:15:37.000Z - 6 months ago

LB Pharmaceuticals appoints Kaya Pai Panandiker as CCO

LBRX


Neumora Therapeutics reports Q3 EPS (35c), consensus (34c)

2025-11-06T12:06:36.000Z - 6 months ago

Neumora Therapeutics reports Q3 EPS (35c), consensus (34c)


Neumora Therapeutics upgraded to Buy from Neutral at Guggenheim

2025-10-27T12:06:02.000Z - 7 months ago

Neumora Therapeutics upgraded to Buy from Neutral at Guggenheim


Neumora Therapeutics Transcript: R&D Day 2025

Oct 27, 2025, 8:00 AM EDT - 7 months ago

Neumora Therapeutics Transcript: R&D Day 2025


Neumora Therapeutics’ NMRA-215 shows weight loss efficacy

2025-10-27T10:40:05.000Z - 7 months ago

Neumora Therapeutics’ NMRA-215 shows weight loss efficacy


Neumora Therapeutics to Host Virtual R&D Day on October 27

Oct 1, 2025, 7:00 AM EDT - 8 months ago

Neumora Therapeutics to Host Virtual R&D Day on October 27


Neumora Therapeutics Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 9 months ago

Neumora Therapeutics Earnings Call Transcript: Q2 2025


Neumora Therapeutics Earnings Call Transcript: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Neumora Therapeutics Earnings Call Transcript: Q1 2025


Neumora Therapeutics Earnings Call Transcript: Q4 2024

Mar 3, 2025, 8:00 AM EST - 1 year ago

Neumora Therapeutics Earnings Call Transcript: Q4 2024


GangsterX
GangsterX May. 12 at 6:15 PM
$CHRS $NMRA small bet couple weeks ago and still holding
1 · Reply
Kaltycoon
Kaltycoon May. 12 at 6:15 PM
$LCTX $NMRA tanked 25% on slight beat and no updates, just saying as I’m invested in both
0 · Reply
Kaltycoon
Kaltycoon May. 11 at 1:16 PM
0 · Reply
Kaltycoon
Kaltycoon May. 9 at 7:30 AM
$NMRA wonder when this transaction happened timeline
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW May. 8 at 7:36 PM
$NMRA options flow has spoken, slap that ask if you want in, this is the way….
0 · Reply
Kaltycoon
Kaltycoon May. 8 at 7:16 PM
$NMRA someone made a swing short here, also bunch of people got stopped out:
0 · Reply
Only_Bulls
Only_Bulls May. 8 at 6:48 PM
$NMRA increased my position by 20% today! Let’s Goooo! Thanks for the cheapies!
0 · Reply
Kaltycoon
Kaltycoon May. 8 at 3:54 PM
$NMRA latest 10Qs are transparent, just need better and cleaner updates on trials with peer reviews. Where there is risk, there is reward.
0 · Reply
Kaltycoon
Kaltycoon May. 8 at 2:45 PM
$NMRA $MRNA the only way is up, the year of biotech
2 · Reply
InvestorCG
InvestorCG May. 8 at 2:27 PM
$NMRA These are the times that try mans souls.
0 · Reply
Kaltycoon
Kaltycoon May. 7 at 10:40 PM
$NMRA most biotech is down today, readouts not too good, can Neumora be in the 10% that succeeds?!
0 · Reply
InvestorCG
InvestorCG May. 7 at 8:27 PM
$NMRA 10 Q is out. K2 converted most if not all of their .87 share conversions, but still has their $2.30+ ones left. Ha, underwater. F them. What is more concerning to me is D-bag management hit the ATM already in 2026. Diluting still in the $2 range.....SHAME SHAME SHAME ON YOU GUYS. "During the three months ended March 31, 2026, we received aggregate net proceeds of $10.9 million through sales of shares of our common stock under the ATM after deducting commissions and offering expenses."
1 · Reply
Kaltycoon
Kaltycoon May. 7 at 5:43 PM
$NMRA could have been major stop loss raid to collect cheap shares and smth good is cooking, either more shares added and awaiting the results.
0 · Reply
AshleySchaeffer_BMW
AshleySchaeffer_BMW May. 7 at 3:30 PM
$NMRA added 200 July 2.5 calls, good vol there today, this will do well on good P3 data read out
1 · Reply
Arrifano
Arrifano May. 7 at 3:08 PM
$NMRA Good results but what we know is in Q2. I hold my position and will buy +500 shares on this dip. I still believe in the company. What they have done so far is incredible. Come on💪🏻🤑
0 · Reply
Kaltycoon
Kaltycoon May. 7 at 2:39 PM
$NMRA no update because it’s not looking too good, I assume. Some tutes derisking.
1 · Reply
Kaltycoon
Kaltycoon May. 7 at 2:02 PM
$NMRA the up channel is collapsing.
0 · Reply
soccerden
soccerden May. 7 at 1:58 PM
$NMRA why the drop i didnt see anything negative? Did i miss something??
1 · Reply
Ash904
Ash904 May. 7 at 1:57 PM
$NMRA such an overreaction to earnings…get ready for that oversold bounce imo
0 · Reply
QulckTrade
QulckTrade May. 7 at 1:56 PM
$NMRA good news but still need to wait for results.. in Q2
0 · Reply
InvestorCG
InvestorCG May. 7 at 1:31 PM
$NMRA THE GOOD: K came out on time, Navacaprant still on schedule THE BAD: Why no conference call for the update? Someone tell me they have good vibes about Phase 3 results about to come..........
1 · Reply
Kaltycoon
Kaltycoon May. 7 at 1:11 PM
$NMRA looks like they are managing cash better, some dilution yoy probably loan sharks converting. No major update but I like that report came out on time.
0 · Reply